WASHINGTON, Dec 5 (Reuters) - U.S. health regulators on Monday said a CardioMEMs implant for treating heart failure met its main safety and effectiveness targets but warned of potential bias in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback